Gleevec(Registered tradmark) in the Treatment of Inflammatory Arthritis

reportActive / Technical Report | Accession Number: ADA529815 | Open PDF

Abstract:

Tyrosine Kinase inhibitors are an area of rapidly evolving medications in Rheumatoid Arthritis. There is currently no information beyond case reports and thus a retrospective review of a large database of records of patients could yield additional insight about the true efficacy of Gleevec in treating inflammatory arthritis. While 13 records were identified in the search of M2 requested by this protocol, only 2 records had enough information in AHLTA for a meaningful review. Of these 2, only 1 satisfied the search criteria but only partial records were available.

Author(s):
Carroll, Matthew
Author Organization(s):
AIR FORCE MEDICAL GROUP ( 81ST) KEESLER AFB MS CLINICAL RESEARCH LAB
Descriptive Note:
Final rept. 19 Dec 2009-1 Jun 2010
Supplementary Note:
DOI: 10.21236/ADA529815
Pagination:
0003

Security Markings

DOCUMENT & CONTEXTUAL SUMMARY

Distribution:
Approved For Public Release
Distribution Statement:
Approved For Public Release; Distribution Is Unlimited.

RECORD

Collection: TR
Identifying Numbers
Report Number(s):
FKE20100008E
Monitor Series:
81MG/CRL
 Subject Terms
Communities of Interest:
No COI(s) Identified
Descriptor(s):
*MEDICAL RESEARCH, *ARTHRITIS, *TYROSINE, PHOSPHORUS TRANSFERASES, PATIENTS, FILES(RECORDS)
Field(s)/Group(s):
Medicine and Medical Research, Pharmacology
Keyword(s):
INFLAMMATORY ARTHRITIS, TYROSINE KINASE INHIBITORS, RETROSPECTIVE REVIEWS
Report Date:
2010 Jul 30
Creation Date:
2010 Oct 13